Tactile Medical Q2 revenue $59.6M (+17% YoY); raises FY22 revenue guidance to $238-242M

TACTILE SYSTEMS TECHNOLOGY INC

2022-Q2 EPS reported -$1.01 revenue$107,623,000

Net loss $4.6M ($0.23/share) vs net income $1.3M ($0.07) in Q2 2021; adjusted EBITDA $1.7M vs $4.1M.
Airway clearance products added $8.0M revenue; lymphedema sales up 1% YoY.
Full-year 2022 revenue guidance raised to $238-242M from prior $235-240M (14-16% growth).
Operating loss widened to $4.1M from $0.1M; cash $23.4M, debt $50.5M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.